nach oben

AIDS and Behavior

Erschienen in:

06.01.2017 | Original Paper

A Hazard Analysis of Risk Factors of Mortality in Individuals Who Inject Drugs in Denver CO

verfasst von: Jonathan M. Davis, Katie Suleta, Karen F. Corsi, Robert E. Booth

Erschienen in: AIDS and Behavior | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Despite multiple risk factors for mortality among People Who Inject Drugs (PWID), more research is warranted that examines sub-populations within PWID. Mortality data from PWID participating in longitudinal HIV prevention research in Denver were obtained from The Colorado Department of Public Health and Environment. Risk factors for both all-cause and acute-toxicity related mortality were analyzed using Cox proportional hazards regression. Two-thousand seven individuals were interviewed at baseline. Eighty-six individuals died during the time frame of the study, 58 of which were due to acute-toxicity. Disabled (HR = 3.3, p < 0.001), gay/lesbian-identified (HR = 2.6, p = 0.03), white race/ethnicity (HR = 2.4, p = 0.003), and use of a shared cooker (HR = 2.1, p = 0.01) were important adjusted risk factors. These suggest that drug and HIV interventions should utilize techniques that can address the needs of marginalized populations in addition to HIV drug risk behaviors.

Darke S, Zador D. Fatal heroin “overdose”: a review. Addict Abingdon Engl. 1996;91(12):1765–72.CrossRef

Oppenheimer E, Tobutt C, Taylor C, Andrew T. Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. Addict Abingdon Engl. 1994;89(10):1299–308.CrossRef

Perucci CA, Davoli M, Rapiti E, Abeni DD, Forastiere F. Mortality of intravenous drug users in Rome: a cohort study. Am J Public Health. 1991;81(10):1307–10.CrossRefPubMedPubMedCentral

Vaillant GE. A 20-year follow-up of New York narcotic addicts. Arch Gen Psychiatr. 1973;29(2):237–41.CrossRefPubMed

Hulse GK, English DR, Milne E, Holman CD. The quantification of mortality resulting from the regular use of illicit opiates. Addict Abingdon Engl. 1999;94(2):221–9.CrossRef

Frischer M, Bloor M, Goldberg D, Clark J, Green S, McKeganey N. Mortality among injecting drug users: a critical reappraisal. J Epidemiol Community Health. 1993;47(1):59–63.CrossRefPubMedPubMedCentral

Mathers BM, Degenhardt L, Bucello C, Lemon J, Wiessing L, Hickman M. Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ. 2013;91(2):102–23.CrossRefPubMedPubMedCentral

Artenie AA, Bruneau J, Zang G, Lespérance F, Renaud J, Tremblay J, et al. Associations of substance use patterns with attempted suicide among persons who inject drugs: can distinct use patterns play a role? Drug Alcohol Depend. 2015;1(147):208–14.CrossRef

Marshall BDL, Galea S, Wood E, Kerr T. Injection methamphetamine use is associated with an increased risk of attempted suicide: a prospective cohort study. Drug Alcohol Depend. 2011;119(1–2):134–7.CrossRefPubMedPubMedCentral

10.

Hayden A, Hayashi K, Dong H, Milloy M-J, Kerr T, Montaner JS, et al. The impact of drug use patterns on mortality among polysubstance users in a Canadian setting: a prospective cohort study. BMC Public Health [Internet]. 2014 Nov 6 [cited 2015 Sep 25];14. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246520/.

11.

Selwyn PA, Hartel D, Wasserman W, Drucker E. Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. Am J Public Health. 1989;79(10):1358–62.CrossRefPubMedPubMedCentral

12.

Gjersing L, Bretteville-Jensen AL. Gender differences in mortality and risk factors in a 13-year cohort study of street-recruited injecting drug users. BMC Public Health. 2014;14:440.CrossRefPubMedPubMedCentral

13.

Zivanovic R, Milloy MJ, Hayashi K, Dong H, Sutherland C, Kerr T, et al. Impact of unstable housing on all-cause mortality among persons who inject drugs. BMC Public Health. 2015;15:106.CrossRefPubMedPubMedCentral

14.

Borriello R, Carfora A, Cassandro P, Petrella R. A five years study on drug-related deaths in Campania (Italy). Ann DellIstituto Super Sanità. 2014;50(4):328–33.

15.

Grant BF, Harford TC. Concurrent and simultaneous use of alcohol with cocaine: results of national survey. Drug Alcohol Depend. 1990;25(1):97–104.CrossRefPubMed

16.

O’Driscoll PT, McGough J, Hagan H, Thiede H, Critchlow C, Alexander ER. Predictors of accidental fatal drug overdose among a cohort of injection drug users. Am J Public Health. 2001;91(6):984–7.CrossRefPubMedPubMedCentral

17.

Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addict Abingdon Engl. 2011;106(1):32–51.CrossRef

18.

Langendam MW, van Brussel GH, Coutinho RA, van Ameijden EJ. The impact of harm-reduction-based methadone treatment on mortality among heroin users. Am J Public Health. 2001;91(5):774–80.CrossRefPubMedPubMedCentral

19.

Binswanger IA, Blatchford PJ, Mueller SR, Stern MF. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med. 2013;159(9):592–600.CrossRefPubMedPubMedCentral

20.

Binswanger IA, Blatchford PJ, Lindsay RG, Stern MF. Risk factors for all-cause, overdose and early deaths after release from prison in Washington state. Drug Alcohol Depend. 2011;117(1):1–6.CrossRefPubMed

21.

Mathers BM, Degenhardt L. Examining non-AIDS mortality among people who inject drugs. AIDS Lond Engl. 2014;28(Suppl 4):S435–44.CrossRef

22.

Islam MM, Topp L, Day CA, Dawson A, Conigrave KM. The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: a narrative synthesis of literature. Int J Drug Policy. 2012;23(2):94–102.CrossRefPubMed

23.

Booth RE, Kwiatkowski C, Iguchi MY, Pinto F, John D. Facilitating treatment entry among out-of-treatment injection drug users. Public Health Rep. 1998;113(1):116–28.PubMedPubMedCentral

24.

Booth RE, Corsi KF, Mikulich SK. Improving entry to methadone maintenance among out-of-treatment injection drug users. J Subst Abuse Treat. 2003;24(4):305–11.CrossRefPubMed

25.

Evans E, Kelleghan A, Li L, Min J, Huang D, Urada D, et al. Gender differences in mortality among treated opioid dependent patients. Drug Alcohol Depend. 2015;1(155):228–35.CrossRef

26.

Forman-Hoffman VL, Ault KL, Anderson WL, Weiner JM, Stevens A, Campbell VA, et al. Disability status, mortality, and leading causes of death in the United States community population. Med Care. 2015;53(4):346–54.PubMedPubMedCentral

27.

Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379(9810):55–70.CrossRefPubMed

28.

Ives TJ, Chelminski PR, Hammett-Stabler CA, Malone RM, Perhac JS, Potisek NM, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res. 2006;6:46.CrossRefPubMedPubMedCentral

29.

Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. J Pain Symptom Manag. 2004;28(2):176–88.CrossRef

30.

Mars SG, Bourgois P, Karandinos G, Montero F, Ciccarone D. “Every ‘never’ I ever said came true”: transitions from opioid pills to heroin injecting. Int J Drug Policy. 2014;25(2):257–66.CrossRefPubMed

31.

Link BG, Phelan JC. Stigma and its public health implications. Lancet. 2006;367(9509):528–9.CrossRefPubMed

32.

Hatzenbuehler ML, Bellatorre A, Lee Y, Finch BK, Muennig P, Fiscella K. Structural stigma and all-cause mortality in sexual minority populations. Soc Sci Med. 2014;103:33–41.CrossRefPubMed

33.

Meyer IH. Minority stress and mental health in gay men. J Health Soc Behav. 1995;36(1):38–56.CrossRefPubMed

34.

Nambiar D, Weir A, Aspinall EJ, Stoové M, Hutchinson S, Dietze P, et al. Mortality and cause of death in a cohort of people who had ever injected drugs in Glasgow: 1982–2012. Drug Alcohol Depend. 2015;1(147):215–21.CrossRef

35.

Bargagli AM, Hickman M, Davoli M, Perucci CA, Schifano P, Buster M, et al. Drug-related mortality and its impact on adult mortality in eight European countries. Eur J Public Health. 2006;16(2):198–202.CrossRefPubMed

36.

Degenhardt L, Singleton J, Calabria B, McLaren J, Kerr T, Mehta S, et al. Mortality among cocaine users: a systematic review of cohort studies. Drug Alcohol Depend. 2011;113(2–3):88–95.CrossRefPubMed

37.

Bauer UE, Briss PA, Goodman RA, Bowman BA. Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA. Lancet Lond Engl. 2014;384(9937):45–52.CrossRef

38.

Armour BS, Campbell VA, Crews JE, Malarcher A, Maurice E, Richard RA. State-level prevalence of cigarette smoking and treatment advice, by disability status, United States, 2004. Prev Chronic Dis. 2007;4(4):A86.PubMedPubMedCentral

39.

Carroll DD, Courtney-Long EA, Stevens AC, Sloan ML, Lullo C, Visser SN, et al. Vital signs: disability and physical activity–United States, 2009–2012. MMWR Morb Mortal Wkly Rep. 2014;63(18):407–13.PubMed

40.

Kinne S, Patrick DL, Doyle DL. Prevalence of secondary conditions among people with disabilities. Am J Public Health. 2004;94(3):443–5.CrossRefPubMedPubMedCentral

41.

Dilley JA, Simmons KW, Boysun MJ, Pizacani BA, Stark MJ. Demonstrating the importance and feasibility of including sexual orientation in public health surveys: health disparities in the Pacific Northwest. Am J Public Health. 2010;100(3):460–7.CrossRefPubMedPubMedCentral

42.

Garland-Forshee RY, Fiala SC, Ngo DL, Moseley K. Sexual orientation and sex differences in adult chronic conditions, health risk factors, and protective health practices, Oregon, 2005–2008. Prev Chronic Dis. 2014;11:E136.CrossRefPubMedPubMedCentral

43.

Coffin PO, Galea S, Ahern J, Leon AC, Vlahov D, Tardiff K. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990–1998. Addict Abingdon Engl. 2003;98(6):739–47.CrossRef

44.

Leece P, Cavacuiti C, Macdonald EM, Gomes T, Kahan M, Srivastava A, et al. Predictors of opioid-related death during methadone therapy. J Subst Abuse Treat. 2015;57:30–5.CrossRefPubMed

45.

Darke S, Williamson A, Ross J, Teesson M, Lynskey M. Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend. 2004;74(1):77–83.CrossRefPubMed

46.

Mackesy-Amiti ME, Donenberg GR, Ouellet LJ. Psychiatric correlates of injection risk behavior among young people who inject drugs. Psychol Addict Behav J Soc Psychol Addict Behav. 2014;28(4):1089–95.CrossRef

47.

Fossati A, Barratt ES, Carretta I, Leonardi B, Grazioli F, Maffei C. Predicting borderline and antisocial personality disorder features in nonclinical subjects using measures of impulsivity and aggressiveness. Psychiatry Res. 2004;125(2):161–70.CrossRefPubMed

48.

Teese R, Bradley G. Predicting recklessness in emerging adults: a test of a psychosocial model. J Soc Psychol. 2008;148(1):105–26.CrossRefPubMed

49.

Carpenter RW, Trull TJ. Components of emotion dysregulation in borderline personality disorder: a review. Curr Psychiatry Rep. 2013;15(1):335.CrossRefPubMedPubMedCentral

50.

Buster MCA, van Brussel GHA, van den Brink W. An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam. Addict Abingdon Engl. 2002;97(8):993–1001.CrossRef

51.

Caplehorn JR, Dalton MS, Haldar F, Petrenas AM, Nisbet JG. Methadone maintenance and addicts’ risk of fatal heroin overdose. Subst Use Misuse. 1996;31(2):177–96.CrossRefPubMed

52.

Cousins G, Teljeur C, Motterlini N, McCowan C, Dimitrov BD, Fahey T. Risk of drug-related mortality during periods of transition in methadone maintenance treatment: a cohort study. J Subst Abuse Treat. 2011;41(3):252–60.CrossRefPubMed

53.

Harlow KC. Patterns of rates of mortality from narcotics and cocaine overdose in Texas, 1976–1987. Public Health Rep. 1990;105(5):455–62.PubMedPubMedCentral

54.

Shah NG, Lathrop SL, Reichard RR, Landen MG. Unintentional drug overdose death trends in New Mexico, USA, 1990–2005: combinations of heroin, cocaine, prescription opioids and alcohol. Addict Abingdon Engl. 2008;103(1):126–36.CrossRef

55.

Horyniak D, Dietze P, Degenhardt L, Higgs P, McIlwraith F, Alati R, et al. The relationship between age and risky injecting behaviours among a sample of Australian people who inject drugs. Drug Alcohol Depend. 2013;132(3):541–6.CrossRefPubMed

56.

Roth AM, Armenta RA, Wagner KD, Roesch SC, Bluthenthal RN, Cuevas-Mota J, et al. Patterns of drug use, risky behavior, and health status among persons who inject drugs living in San Diego, California: a latent class analysis. Subst Use Misuse. 2015;50(2):205–14.CrossRefPubMed

57.

Del Boca FKN, Jane A. Truth or consequences: the validity of self-report data in health services research on addictions. Addiction. 2000;10(95):S347–60.CrossRef

58.

Harrison L. The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA Res Monogr. 1997;167:17–36.PubMed

Titel: A Hazard Analysis of Risk Factors of Mortality in Individuals Who Inject Drugs in Denver CO
verfasst von: Jonathan M. Davis
Katie Suleta
Karen F. Corsi
Robert E. Booth
Publikationsdatum: 06.01.2017
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 4/2017
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-016-1660-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

A Hazard Analysis of Risk Factors of Mortality in Individuals Who Inject Drugs in Denver CO

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2017

Social Network Factors as Correlates and Predictors of High Depressive Symptoms Among Black Men Who Have Sex with Men in HPTN 061

Pence, Putin, Mbeki and Their HIV/AIDS-Related Crimes Against Humanity: Call for Social Justice and Behavioral Science Advocacy

A Moderated Mediation Model of HIV-Related Stigma, Depression, and Social Support on Health-Related Quality of Life among Incarcerated Malaysian Men with HIV and Opioid Dependence

Effect of Continuing Care for Cocaine Dependence on HIV Sex-Risk Behaviors

Erectile Dysfunction Medication Prescription and Condomless Intercourse in HIV-Infected Men Who have Sex with Men in the United States

The Relationship Between Methamphetamine Use, Sexual Sensation Seeking and Condomless Anal Intercourse Among Men Who Have Sex With Men in Vietnam: Results of a Community-Based, Cross-Sectional Study

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin